Disease ID | Disease name | Source of annotation with KIR3DL1 | OMIM link | Number of associated genes | genes |
---|---|---|---|---|---|
609423 | HUMAN IMMUNODEFICIENCY VIRUS TYPE 1, SUSCEPTIBILITY TO | OMIM | link to OMIM | 16 | HLA-C, IFNG, CCL3, CD209, IL4R, KIR3DL1, CCL2, TLR3, CCR2, CX3CR1, CCL11, CCR5, CXCL12, CCL3L1, CXCR1, IL10 |
Download the gene annotation in CSV format
KEGG pathway | KEGG ID | KEGG IC |
---|---|---|
Natural killer cell mediated cytotoxicity | hsa04650 | 5.53 |
Graft-versus-host disease | hsa05332 | 6.84 |
Antigen processing and presentation | hsa04612 | 6.04 |
REACTOME pathway | REACTOME ID | REACTOME IC |
---|---|---|
Immune System | R-HSA-168256 | 2.37 |
Adaptive Immune System | R-HSA-1280218 | 3.19 |
Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell | R-HSA-198933 | 4.7 |
GO term | GO ID | GO IC |
---|---|---|
MHC class I receptor activity | GO:0032393 | 7.44 |
signaling receptor activity | GO:0038023 | 2.49 |
inhibitory MHC class I receptor activity | GO:0032396 | 8.35 |
molecular transducer activity | GO:0060089 | 2.32 |
transmembrane signaling receptor activity | GO:0004888 | 2.57 |
receptor activity | GO:0004872 | 2.32 |
signal transducer activity | GO:0004871 | 2.28 |
transmembrane receptor activity | GO:0099600 | 2.53 |
HLA-B specific inhibitory MHC class I receptor activity | GO:0030109 | 9.05 |